Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

[wpdts-date-time]  

Imagen tomada de Twitter.

Después de que el gobierno anunciara que el intervalo entre la primera y la segunda dosis de Moderna pasa a ser de 12 semanas, el Departamento Administrativo de la Presidencia de la República (DAPRE) confirmó que la farmacéutica Moderna tiene retrasos en la entrega de dosis a nivel global. 

El director del DAPRE, Víctor Muñoz, resaltó que, aunque el gobierno tiene confirmado el envío de dosis de vacunas de Pfizer, Janssen, Sinovac y AstraZeneca, con Moderna no se ha confirmado el envío de dosis, debido a que “tiene inconvenientes para cumplir con las fechas que tenían estipuladas”, señaló Muñoz en entrevista con Caracol Radio.

Para cumplir con las fechas de entrega a escala global, la farmacéutica estaría pensando recurrir a otros gobiernos como el de Estados Unidos, para tomar parte de sus vacunas, entregarlas a los países con los que tienen contrato y luego reponerlas, esto considerando que EE.UU. ha estado donando dosis de Moderna en las últimas semanas.